SMTL ID : 6fuo.1

F11 T-Cell Receptor Recognising PKYVKQNTLKLAT Peptide Presented by HLA-DR*0101

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

hetero-1-1-mer

Ligands

24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 8 residues within 4Å: Chain A: L.111, P.112, I.114, D.141, S.142, K.159, N.172 Ligands: EDO.2 Ligand excluded by PLIP EDO.2: 7 residues within 4Å: Chain A: S.14, E.15, L.111, P.112, N.113, S.142 Ligands: EDO.1 Ligand excluded by PLIP EDO.3: 5 residues within 4Å: Chain A: N.61, K.78, P.79, S.80, H.82 Ligand excluded by PLIP EDO.4: 7 residues within 4Å: Chain A: V.121, Q.123, C.185, A.186, F.200, P.201 Ligands: GOL.15 Ligand excluded by PLIP EDO.5: 6 residues within 4Å: Chain A: L.7, V.11, L.20, L.21, R.22, T.106 Ligand excluded by PLIP EDO.6: 6 residues within 4Å: Chain A: K.132, S.133, W.177, S.178 Chain B: F.124, L.142 Ligand excluded by PLIP EDO.7: 5 residues within 4Å: Chain A: E.64, A.65, E.66, H.75, T.77 Ligand excluded by PLIP EDO.8: 7 residues within 4Å: Chain A: G.43, L.44 Chain B: F.89, F.101, G.102, S.103 Ligands: PEG.14 Ligand excluded by PLIP EDO.9: 3 residues within 4Å: Chain A: Y.39, S.84, D.85 Ligand excluded by PLIP EDO.10: 6 residues within 4Å: Chain A: S.3, V.4, I.101, F.102, G.103 Ligands: EDO.26 Ligand excluded by PLIP EDO.11: 2 residues within 4Å: Chain A: N.145, V.146 Ligand excluded by PLIP EDO.17: 7 residues within 4Å: Chain B: R.17, M.19, S.64, V.65, S.66, S.74, S.76 Ligand excluded by PLIP EDO.18: 5 residues within 4Å: Chain B: L.113, N.114, E.218, W.219, T.220 Ligand excluded by PLIP EDO.19: 4 residues within 4Å: Chain B: T.85, A.86, R.106, L.107 Ligand excluded by PLIP EDO.20: 5 residues within 4Å: Chain B: D.2, T.4, S.23, Q.24, T.25 Ligand excluded by PLIP EDO.21: 8 residues within 4Å: Chain B: R.35, D.61, G.62, Y.63, I.81, N.83, Q.84 Ligands: EDO.23 Ligand excluded by PLIP EDO.22: 5 residues within 4Å: Chain B: G.57, E.58, I.59, S.60, D.61 Ligand excluded by PLIP EDO.23: 4 residues within 4Å: Chain B: R.35, R.43, N.83 Ligands: EDO.21 Ligand excluded by PLIP EDO.24: 5 residues within 4Å: Chain B: Y.46, K.56, S.60, D.61, Y.63 Ligand excluded by PLIP EDO.25: 1 residues within 4Å: Chain B: R.17 Ligand excluded by PLIP EDO.26: 9 residues within 4Å: Chain A: F.102, G.103, K.104 Chain B: L.40, G.41, L.42, R.43, E.58 Ligands: EDO.10 Ligand excluded by PLIP EDO.27: 3 residues within 4Å: Chain B: W.156, K.160, E.161 Ligand excluded by PLIP EDO.28: 5 residues within 4Å: Chain B: K.26, H.28, D.94, G.98, T.100 Ligand excluded by PLIP EDO.29: 4 residues within 4Å: Chain B: W.219, Q.221, D.222, R.223 Ligand excluded by PLIP

4 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.12: 3 residues within 4Å: Chain A: H.109, K.159, V.161 3 PLIP interactions: 3 interactions with chain A Water bridges: A:I.110, A:I.110, A:K.159 PEG.13: 6 residues within 4Å: Chain A: I.114, Q.115, N.116, D.168, F.169, K.170 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:N.116, A:N.116, A:D.168, A:K.170 Water bridges: A:Q.115, A:Q.115 PEG.14: 8 residues within 4Å: Chain A: Y.36, L.44, Q.45, L.46 Chain B: Y.99, T.100, F.101 Ligands: EDO.8 3 PLIP interactions: 1 interactions with chain A, 2 interactions with chain B Hydrogen bonds: A:L.46, B:F.101, B:F.101 PEG.30: 5 residues within 4Å: Chain B: V.162, H.163, S.164, V.192, F.196 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:H.163, B:S.164 Water bridges: B:S.164

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.15: 8 residues within 4Å: Chain A: Y.122, Q.123, P.201, S.202 Chain B: S.127, E.128, A.129 Ligands: EDO.4 6 PLIP interactions: 2 interactions with chain A, 4 interactions with chain B Hydrogen bonds: A:Q.123, A:P.201, B:S.127, B:S.127, B:E.128, B:A.129

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.16: 5 residues within 4Å: Chain A: E.15, G.16, S.80, A.81, H.82 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:E.15, A:G.16, A:A.81 Salt bridges: A:H.82

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Holland, C.J. et al., In Silicoand Structural Analyses Demonstrate That Intrinsic Protein Motions Guide T Cell Receptor Complementarity Determining Region Loop Flexibility. Front Immunol (2018)

Release Date

2018-04-18

Peptides

Human F11 T-Cell Receptor alpha chain: A
Human F11 T-Cell Receptor: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Human F11 T-Cell Receptor alpha chain

Human F11 T-Cell Receptor

Related Entries With Identical Sequence